Naltrexone does not attenuate the acute behavioral effects of ethanol or pentobarbital in humans

Behavioural Pharmacology

Volumn 10, Issue 4, 1999, Pages 401-413

  Rush, C R ^a,b,c   Ali, J A ^a  

^a Dept of Psychiat/Hum Behavior ^*  (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alcohol; Barbiturates; Ethanol; Human; Naltrexone; Opioid antagonists; Opioids; Pentobarbital; Performance; Subjective effects

Indexed keywords

ALCOHOL; NALTREXONE; OPIATE ANTAGONIST; PENTOBARBITAL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SENSITIVITY; DRUNKENNESS; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PERFORMANCE; PHYSIOLOGY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

EID: 0032717181     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199907000-00007     Document Type: Article

References (44)

1. Ågmo A, Galvan A, Heredia A, Morales M (1995). Naloxone blocks the antianxiety but not the motor effects of benzodiazepines and pentobarbital: experimental studies and literature review. Psychopharmacology 120:186-194.
2. Altman JL, Alert JM, Milstein SL, Greenberg I (1977). Drugs as discriminable events in humans. In: Discriminative stimulus properties of drugs. Lal H (editor). New York: Plenum Press, pp. 187-206.
3. Boyle AE, Stewart RB, Macenski MJ, Spiga R, Johnson BA, Meisch RA (1998). Effects of acute and chronic doses of naltrexone on ethanol self-administration in rhesus monkeys. Alcohol Clin Exp Res 22:359-366.
4. Davidson D, Amit Z (1997). Effect of ethanol drinking and naltrexone on subsequent drinking in rats. Alcohol 14:581-584.
5. de Wit H, Svenson J (1997). Effect of naltrexone on ethanol consumption in social drinkers. Paper presented at the annual meeting of the American College of Neuropsychopharmacology, Waikoloa, HI.
6. de Wit H, Bodker B, Ambre J (1992). Rate of increase of plasma drug level influences subjective response in humans. Psychopharmacology 107:352-358.
7. Doty P, de Wit H (1995). Effects of naltrexone pretreatment on the subjective and performance effects of ethanol in social drinkers. Behav Pharmacol 6:386-394.
8. Doty P, Kirk JM, Cramblett MJ, de Wit H (1997). Behavioral responses to ethanol in light and moderate social drinkers following naltrexone pretreatment. Drug Alcohol Depend 47:109-116.
9. Ewing JA, Mills KC, Bisgrove EZ, McManus K (1984). Selective attenuation of ethanol-induced performance impairment by naloxone in humans. Adv Alcohol Subst Abuse 4:347-359.
10. Griffiths RR, Bigelow, GE, Liebson I (1983). Differential effects of diazepam and pentobarbital on mood and behavior. Arch Gen Psychiaty 40:865-873.
11. Higgins ST, Rush CR, Hughes JR, Bickel WK, Lynn M, Capless MA (1993). Acute behavioral and cardiac effects of cocaine and alcohol combinations in humans. Psychopharmacology 111:285-294.
12. Higgins ST, Roll JM, Bickel WK (1996). Alcohol pretreatment increases preference for cocaine over monetary reinforcement. Psychopharmacology 123:1-8.
13. Hobbs WK, Rall TW, Verdoorn TA (1996). Hypnotics and sedatives; ethanol. In: Goodman's and Gilman's: the pharmacological basis of therapeutics (9th ed.). Hardman JG, Limbird LE, Molinoff, Ruddon RW, Gilman AG (editors). New York: McGraw-Hill, pp. 361-398.
14. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC (1973). Quantification of sleepiness: a new approach. Psychophysiology 10:431-436.
15. Jasinski D (1977). Assessment of the abuse potentiality of morphine-like drugs (methods used in man). In: Drug addiction I. Martin WR (editor). New York: Springer, pp. 147-258.
16. Kelly TH, Emurian CS, Baseheart BJ, Martin CA (1997). Discriminative stimulus effects of alcohol in humans. Drug Alcohol Depend 48:199-207.
17. King AC, Volpicell JR, Frazer A, O'Brien CP (1997). Effect of naltrexone on subjective response in subjects at high and low risk for future alcohol dependence. Psychopharmacology 129:15-22.
18. Kirk T, Roache JD, Griffiths RR (1990). Dose-response evaluation of the amnestic effects of triazolam and pentobarbital in normal subjects. J Clin Psychopharmacol 10:160-167.
19. Lamb RJ, Preston KL, Schindler CW, Meisch RA, Davis F, Katz JL et al. (1991). The reinforcing and subjective effects of morphine in post-addicts: a dose-response study. J Pharmacol Exp Ther 259:1165-1173.
20. Maisto SA, Connors GJ, Tucker JA, McCollam JB (1980). Validation of the sensation scale, a measure of subjective physiological responses to alcohol. Behav Res Ther 18:37-43.
21. Martin WR, Sloan JW, Sapiro JD, Jasinski DR (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man, Clin Pharmacol Ther 12:245-258.
22. McKay MA, Lichtor JL, Apfelbaum J, Flemming D, Han L, Zacny JP (1993). Is it feasible to use nitrous oxide as a discriminative stimulus in humans? Paper presented at the annual meeting of the Association for Behavior Analysis, Chicago, IL.
23. McLeod DR, Griffiths RR, Bigelow GE, Yingling JE (1982). An automated version of the digit symbol substitution test (DSST). Behav Res Method Instrum 14:463-466.
24. Mintzer MZ, Guarino J, Kirk T, Roache JD, Griffiths RR (1997). Ethanol and pentobarbital: comparison of behavioral and subjective effects in sedative abusers. Exp Clin Psychophamacol 5:203-215.
25. Mumford GK, Rush CR, Griffiths RR (1995a), Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects. J Pharmacol Exp Ther 272:570-580.
26. Mumford GK, Rush CR, Griffiths RR (1995b). A comparison of the abuse liability of alprazolam and DN-2327 (pazinaclone) in humans: psychomotor, memory, subjective and reinforcing effects. Exp Clin Psychophamacol 3:39-48.
27. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992). Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 49:881-887.
28. Oliveto AH, Bickel WK, Hughes JR, Shea PJ, Higgins ST, Fenwick JW (1992). Caffeine drug discrimination in humans; acquisiton, specificity and correlation with self-reports. J Pharmacol Exp Ther 261:885-894.
29. Physician's Desk Reference (1998). Oradell, NJ: Medical Economics Company, Inc.
30. Preston KL, Bigelow GE (1998). Opioid discrimination in humans: discriminative and subjective effects of progressively lower training dose. Behav Pharmacol 9:533-543.
31. Rafieha S, Spiga R, Macenski M, Meisch RA, Grabowski J, Johnson BA (1997). Effects of work requirement and naltrexone on human ethanol self-administration. NIDA Res Monogr 174:244.
32. Rush CR, Griffiths RR (1996). Zolpidem, triazolam and temazepam: behavioral and subject-rated effects in normal volunteers. J Clin Psychopharmacol 16:146-157.
33. Rush CR, Pazzaglia, PJ (1998). Pretreatment with isradipine, a calcium-channel blocker, does not attenuate the acute behavioral effects of ethanol in humans. Alcohol Clin Exp Res 22:539-547.
34. Rush CR, Higgins ST, Bickel WK, Wiegner MS, Hughes JR (1993). Acute behavioral and cardiac effects of alcohol and caffeine, alone and in combination, in humans. Behav Pharmacol 4:562-572.
35. Rush CR, Madakasira S, Goldman NH, Woolverton WL, Rowlett JK (1997). Discriminative-stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans. J Pharmacol Exp Ther 280:174-188.
36. Stromberg MF, Casale M, Volpicell L, Volicell JR, O'Brien CP (1998). A comparison of the effects of the opioid antagonists naltrexonc, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat. Alcohol 15:281-289.
37. Swift RM, Whelihan W, Kuznetsov O, Buongiorno G, Hsuing H (1994), Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry 151:1463-1467.
38. Swift HM, Davidson D, Rosen S, Fitz E, Camara P (1998). Naltrexone effects of diazepam intoxication and pharmacokinetics. Psychopharmacology 135:256-262.
39. Thompson DM, Moerschbaecher JM (1981). Selective antagonism of the error-increasing effect of morphine by naloxone in a repeated-acquisition task. J Exp Anal Behav 36:371-380.
40. Vereby K, Volavda J, Mule SJ, Resnick RB (1976). Naltrexone: disposition, metabolism, and effects after acute and chronic dosing. Clin Pharmacol Ther 20:315-328.
41. Volpicelli JR, Alterman AI, Hayashidea M, O'Brien CP (1992). Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880.
42. Volpicelli JR, Watson NT, King AC, Sherman CE, O'Brien CP (1995). Effect of naltrexone on alcohol 'high' in alcoholic. Am J Psychiatry 152:613-615.
43. Williams KL, Winger G, Pakarinen ED, Woods JH (1998). Naltrexone reduces ethnaol- and sucrose-reinforced responding in rhesus monkeys. Psychopharmacology 139:53-61.
44. Zacny JP, Coalson DW, Lichtor JL, Yajnik S, Thapar P (1994). Effects of naloxone on the subjective and psychomotor effects of nitrous oxide in humans. Pharmacol Biochem Behav 49:573-578.